Hypertension Drugs Market Trends

  • Report ID: 2845
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Hypertension Drugs Market Trends

Growth Drivers

  • Increasing Prevalence of Renal Disease- renal disease is a medical condition in which kidneys are damaged and lose their capability to filter blood causing severe health problems such as hypertension is one of them. For instance, around 800 million people across the globe are observed to be living with some sort of renal disease.
  • Rising Trend of Work from Home (WFH) – work from home is a process that involves less mobility that can cause strain in arteries carrying blood. Hence, working from home is noticed to be one of the major reasons. Around 80% of the employees were observed to prefer working from home while by the year 2025, around 35 million Americans will be working remotely.
  • Growing Consumption of Tobacco and Cigarette- smoking habits and tobacco consumption can be one of the major causes of hypertension since it was noticed to increase blood pressure and masked hypertension. For instance, it was estimated that around 8 million people die annually owing to the consumption of tobacco.

Challenges

  • Rising Number of Alternate Generic Drugs- There is an increase in the number of generic drugs and other substitutes associated with the treatment of hypertension which negatively affects the market growth. Further, the presence of some side effects of these drugs is estimated to hinder the growth of the global hypertension drugs market during the forecast period.
  • Possibilities of Side-Effect such as Dizziness and Headaches
  • Higher Cost Associated with Hypertension Drugs

Hypertension Drugs Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

4.3%

Base Year Market Size (2024)

USD 21.85 billion

Forecast Year Market Size (2037)

USD 37.11 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2845
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hypertension drugs is estimated at USD 22.58 billion.

The hypertension drugs market size was valued at USD 21.85 billion in 2024 and is expected to cross USD 37.11 billion by the end of 2037, registering more than 4.3% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of hypertension around the world and the growing prevalence of insomnia across the globe will boost the market growth.

North America is predicted to account for the largest share of 30% by 2037, impelled by presence of leading industry players in the region.

The major players in the market include Janssen Global Services, LLC, Atnahs Pharma UK Limited, Sanofi US Services Inc., Pfizer Laboratories Div Pfizer Inc, Merck & Co., Inc., Abbott Laboratories, Daiichi Sankyo Company, Limited, Novartis Pharmaceuticals Corporation, Boehringer Ingelheim group, Lupin Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample